chrisvoncsefalvay/vaers-outcomes huggingface dataset:
redness; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm) and ERYTHEMA (redness) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021, the patient experienced MYALGIA (Sore arm). On an unknown date, the patient experienced ERYTHEMA (redness). At the time of the report, MYALGIA (Sore arm) and ERYTHEMA (redness) outcome was unknown.            Concomitant medications were not provided by the reporter. Treatment information was not provided by the reporter.
Pt exp burning @ inject site following vax w/HEP B vax; No further details were provided;
Received vaccine from expired vial; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine from expired vial) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine from expired vial). On 22-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Received vaccine from expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Oct-2021: Non significant follow up appended On 27-Oct-2021: Follow up received contains No New Information
This spontaneous report was received from a registered nurse and refers to a patient of an unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 06-AUG-2018, the patient was supposed to receive a dose of VARIVAX and a dose of M-M-R II but instead inadvertently was vaccinated with a 0.5 ml dose of VARIVAX subcutaneously, lot# N034552, expiration date: 05-DEC-2019 and a 0.5 ml dose of PROQUAD subcutaneously, lot# N013863, expiration date: 31-OCT-2018, for prophylaxis during the same appointment. Both of the administered vaccines were reconstituted with sterile diluent lot # M009789, expiration date: 10-SEP-2018. No symptoms were reported.
I received the bivalent vaccine late September 2022. I got COVID-19 on 12/19/2022.  I started with tickle in my throat and on Tuesday 12/20/2022 when I woke up I felt very ill.  I felt achy, low grade fever, chills, cough. The mornings are the worst and get bad headaches and feel nauseous as well. I had a tele visit on 12/21/2022.  I took Advil the first night and Naproxen last night. My PA also prescribed the Paxlovid but I did not take it mainly due to the side effects. I continue to have my COVID-19 symptoms today.
By the end of the day I received the Pneumococcal Polysaccharide Vaccine (PPSV23), which was 7/10/19, my right shoulder area began to hurt. By the next morning, the pain was so bad that I could hardly move my right arm. By the evening of 7/11/19, the pain associated with any movement of my arm was at the level of 8 out of 10.  Called the doctor on Friday morning. They recommended I go to their Urgent Care if it didn't improve, which I did on Sunday, 7/14/19. At that point, I had some movement pain, but was still in pain (5 out of 10). They attributed the pain to receiving the injection in the wrong place on my right arm (i.e. missed the muscle) and it had caused severe inflammation. They prescribed a strong anti-inflammatory which helped with the pain and has helped me regain 90% of my arm mobility back. I still feel like I don't have full range of motion with the use of my right arm, especially when reaching across my chest or behind my back.
This case was reported by a physician and described a 41 year old male who did not respond to the hep B vaccine recombinant (Engerix B) immunization series. The pt had no relevant medical history, concurrent conditions, or concurrent medications. The pt received injections of hep B vaccine on 2/22/01, 3/20/01, and 8/17/01. An unspecified "titer" measured < 2 on 3/31/02. The pt began another series of injections with Engerix B (5363C6) on 6/13/03. An unspecified "titer" measured < 2 on 7/11/03. On 7/22/03, the pt received the second dose of Engerix B. An unspecified "titer" measured < 2 on 8/19/03. The pt received the third dose of Engerix B (5363C6) on 8/21/03; this dose was administered two months after the first dose, rather than the recommended interval of six months. On 9/15/03, 25 days post-immunization, an unspecified "titer" measured 7.
Information has been received from a physician concerning a female who was vaccinated in the past 3 month with a dose of Gardasil. Subsequently the patient experienced fainted. Medical attention was sought. The patient's outcome was unknown. Follow up information indicated there were 6 patients who after vaccination with a dose of Gardasil fainted and none of them needed resuscitation. Additional information has been requested.
Pt received the shingles vaccine on 11/25/08 for a routine f/u visit.  On 12/10/08, pt called clinic reporting a painful rash to chest and back since 12/6/08.  During urgent visit appt, pt noted to have vesicular rash in T4 dermatome of L chest and back and biopsy taken which was positive (VZV detected).
neck pain; mild headache/Chronic headache; body ache; Very rough 3 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Very rough 3 days), NECK PAIN (neck pain), HEADACHE (mild headache/Chronic headache) and MYALGIA (body ache) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 025B21A) for COVID-19 vaccination.     No Medical History reported.  Concurrent medical conditions included Penicillin allergy. Concomitant products included ATORVASTATIN from 09-Jan-2020 to an unknown date for Cholesterol.   On 28-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced VACCINATION COMPLICATION (Very rough 3 days), HEADACHE (mild headache/Chronic headache) and MYALGIA (body ache). On an unknown date, the patient experienced NECK PAIN (neck pain). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Headache, at a dose of 1 dosage form. On 01-May-2021, VACCINATION COMPLICATION (Very rough 3 days) had resolved. On 28-May-2021, MYALGIA (body ache) had resolved. At the time of the report, NECK PAIN (neck pain) outcome was unknown and HEADACHE (mild headache/Chronic headache) had not resolved.            Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up received on 07-JUL-2021 contains: added information of the events- headache, neck pain; Added event outcomes- from unknown to not recovered and recovered.
Headache, CoughWheeze, ErythemaMultiform, fatigue, chills, low temp, swollen glands, injection site hard, red, "itchy"
Lethargy; Body aches; Chills/shivers; Low grade fever; Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy), PAIN (Body aches), CHILLS (Chills/shivers), PYREXIA (Low grade fever) and INJECTION SITE PAIN (Injection site pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 029A21A) for COVID-19 vaccination.     No reported medical history.  Concomitant products included MULTIVITAMINS [VITAMINS NOS], VITAMIN C [ASCORBIC ACID] and CALCIUM for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021 at 5:30 AM, the patient experienced LETHARGY (Lethargy). 09-Apr-2021 at 5:30 AM, the patient experienced PAIN (Body aches), CHILLS (Chills/shivers), PYREXIA (Low grade fever) and INJECTION SITE PAIN (Injection site pain). On 10-Apr-2021, LETHARGY (Lethargy), PAIN (Body aches), CHILLS (Chills/shivers), PYREXIA (Low grade fever) and INJECTION SITE PAIN (Injection site pain) had resolved.            Treatment information was not provided. Lab details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up information received on 07-MAY-2021, Updated new event Lethargy and outcome of the event low-grade fever as resolved. Added concomitant medications.
Expected reaction; felt like she got the cold; felt like she got the flu; Achy for 24 hrs; Little bit fever; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (Expected reaction), FEELING COLD (felt like she got the cold), INFLUENZA LIKE ILLNESS (felt like she got the flu), PAIN (Achy for 24 hrs) and PYREXIA (Little bit fever) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Expected reaction), FEELING COLD (felt like she got the cold), INFLUENZA LIKE ILLNESS (felt like she got the flu), PAIN (Achy for 24 hrs) and PYREXIA (Little bit fever). At the time of the report, VACCINATION COMPLICATION (Expected reaction), FEELING COLD (felt like she got the cold) and INFLUENZA LIKE ILLNESS (felt like she got the flu) outcome was unknown and PAIN (Achy for 24 hrs) and PYREXIA (Little bit fever) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications reported by reporter No treatment medications provided by the reporter.     This case was linked to MOD-2022-439044, MOD-2022-439068 (Patient Link).
This is a spontaneous report received from a contactable reporter (Physician). The reporter is the patient. A 48-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in arm left, administration date 14Mar2021 16:15 (Lot number: EN6208) at the age of 48 years as dose 1, single for Covid-19 immunisation. Relevant medical history included: "Allergies: Iodine contrast" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DIZZINESS (non-serious) with onset 2021, outcome "unknown", described as "Dizziness CTCAE v 4.03 grade 1 as initial symptom similar to dose 1". Therapeutic measures were not taken as a result of dizziness. Additional Information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. It was unknown if the patient was diagnosed with COVID-19 prior vaccination and has not been tested for COVID-19 since the vaccination. No follow-up attempts are possible. No further information is expected. Sender's Comments: Linked Report(s): US-PFIZER INC-2021402313 same patient/reporter, different vaccine dose and event.
Pt presented to clinic 11/3/10. Rt deltoid erythematous, inflamed, pt reports pruritis at injection site. Denies any SOB, CP, and or generalized sx's. See pt's chart.
Client reports dizziness that started about 2 days ago.  States dizziness is severe enough that she needs to hold onto something or someone to walk.  States this happened last year after flu vaccine also.  She saw MD then and he referred her to an allergist.  MD did some testing and told her the dizziness was caused by the flu vaccine.  He told her it was because a virus from the flu vaccine had "settled in her brain".  He told her this would eventually resolve which it did after 4-5 days.  She states MD did not tell her not to take the flu vaccine again.
pt rcvd vax; pt devel rash; fever; pt tx benadryl;
Pt is in second trimester of pregnancy- Due date 09/2021.  Came to my office 1 week after receiving COVID vaccine with bilateral sub-conjunctival hemorrhages
chills, muscles aches, pains in knees, SOB 1-2 hrs post injection
Redness at injection site. Site was marked and redness extended beyond the marking the next day. Patient came through emergency room. Was vaccinated at another facility, therefore have no vaccine information at this facility.
Pt recvd HIB vax & 2 months following vax noted pt had devel a small nodule @ inject site;
18 x 8 cm area of erythema and increased warmth L shoulder. BENADRYL advised, prednisone 2 tabs qd x 3 days.
RECEIVED COVID VACCINE ON 01/04/22 Later that evening mother noted onset of mildly itchy diffuse rash on face at first When getting ready for bed noted rash all over  Over the next 3 days rash was more itchy and more red and raised The rash is raised. No blisters. No oral or genital lesions He is fussy due to itchiness and was sent home from school for that reason 1/6/22 Itchiness was even worse 1/7/22
UPPER INNER PART OF LEFT ARM STARTED HURTING AND ITCHING AND BY NEXT DAY SYMPTOMS BECAME MORE PRONOUNCED.
Patient had febrile seizure post vaccines. Mom/Parent forgot to give dose of ADVIL before child went to bed.
hearing loss; vision loss; paralysis and numbness of the face; severe pain; paralysis and numbness of the face; constant and severe ringing in ears; other neurologic injuries and episodes; headaches; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported.  On 07-NOV-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot# and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).  Approximately one or two weeks after receiving zoster vaccine live (ZOSTAVAX), patient suffered debilitating injuries including severe pain and paralysis and numbness of the face; constant and severe ringing in ears and hearing loss; headaches; vision loss and other neurologic injuries and episodes. All of these injuries were caused by the zoster vaccine live (ZOSTAVAX)injection. These severe, painful and debilitating injuries "continue today". As a direct and proximate result of zoster vaccine live (ZOSTAVAX), patient's symptoms have resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX) and caused by the zoster vaccine live (ZOSTAVAX) vaccine. As a result of zoster vaccine live (ZOSTAVAX), patient sustained severe and disfiguring personal injuries and suffered serious, progressive, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.  Upon internal review, vision loss, hearing loss and paralysis of the face were considered to be medically significant.
Rash/welts developed over entire body (face, trunk, arms and legs) within 1 hour of receiving vaccine.  Itching started that evening.  Next day went to PCP who ordered 3 doses of prednisone 20mg and benadryl 25mg every 6 hours PRN.  Day 2, rash/welts increased as well as itching.  Evening of day 2, rash to legs progressed to purpura, temp of 102.7, chills and extreme pain to bilateral hips which prompted taking to ED and being admitted to progressive care unit.
left arm pain; red rash with itching around the injection; red rash itching around the injection site; itching around the injection site; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th August 2020, the patient received the 1st dose of Shingrix. On 10th August 2020, less than a week after receiving Shingrix, the patient experienced pain in arm, injection site rash, injection site erythema and injection site itching. On an unknown date, the outcome of the pain in arm was unknown and the outcome of the injection site rash, injection site erythema and injection site itching were recovered/resolved.   It was unknown if the reporter considered the pain in arm, injection site rash, injection site erythema and injection site itching to be related to Shingrix.  Additional details were provided as follows: The patient received 1st dose of Shingrix in left deltoid. On the same of vaccination or the next day, the patient had left arm pain and also red rash with itching around the injection site, which took about 1 week to resolve. The reporter consented to follow up.
This spontaneous report was received from a registered nurse and refers to a 3 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 03-AUG-2017, the patient was vaccinated with an improperly stored PROQUAD at a dose of 0.5 (units not specified), lot # N013865 with expiry date 31-OCT-2018 (dose number, route and anatomical location not reported) for prophylaxis. Concomitant therapies included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1707USA006208:
Had the Pfizer shots and a booster last year and tested positive two weeks ago; Had the Pfizer shots and a booster last year and tested positive two weeks ago; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Had the Pfizer shots and a booster last year and tested positive two weeks ago". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) Positive. Clinical course: It was reported that when queried which Pfizer product he was calling regarding he stated he is actually not. Patient clarified that "he had the Pfizer shots and a booster last year and tested positive two weeks ago". Patient wants to know how long does this thing last or is there anything he can take. Patient stated after a week it is usually over. Patient said it isn't bad it just a cold, like getting a cold. He can't smell, can't taste. Should he call his local doctor. Patient declined to proceed with the report and stated he will call his personal doctor.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This is a spontaneous report from a contactable consumer, reporting for herself. This 67-year-old female patient received PREVNAR 13 about two months before reporting, at single dose at right arm  for immunization. Medical history includes ongoing diabetes. Concomitant medication includes insulin aspart (NOVOLOG). Past vaccination history includes pneumococcal vaccine, about 13 years before.  After the injection, she has experienced right arm pain, arm had not got well at all yet, had pain, swelling comes and goes and arm on the right side is not right, mean it doesn't feel good, had kind of sick at stomach, had a lot of gas. Pain went all around, all over my back, around arm and back on the right side. She underwent lab work, on an unknown date and results were unknown. The outcome of the events was not recovered. The information on the batch number has been requested.
Dizziness after vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness after vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness after vaccine). At the time of the report, DIZZINESS (Dizziness after vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.
01/14/03 16:00 Mom phoned complained of swelling at site of Hib injection. Suggested ice pack and use of Tylenol or Motrin for discomfort. 01/15/03 Mom phoned complained of child breaking out with hives, began at left injection site - pt was on amoxicillin for ear infection. Order from ARNP to stop amoxicillin and begin Benadryl, if no improvement take child to clinic.
pt recv vax & pt exp  a vesicle @ the inj site which cont to spread, with pruritus;